bluebird bio, Inc.
GENOME EDITED IMMUNE EFFECTOR CELLS
Last updated:
Abstract:
The invention provides improved compositions for adoptive immune effector cell therapies for treatment, prevention, or amelioration of numerous conditions including, but not limited to cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency.
Status:
Application
Type:
Utility
Filling date:
10 Mar 2017
Issue date:
8 Aug 2019